Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Proportion of Patients With Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy.

NCT05154474 is registered in ClinicalTrials.gov with Weprom as lead sponsor.

NCT NCT05154474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05154474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Proportion of Patients With Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy.
Lead sponsor
Weprom
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2022
Completion date
August 31, 2024
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer colon, cancer ovaries, cancer pancreas, cancer prostate, cancer, breast, cancer, kidney, cancer, lung, cancer, rectum, leukemia, lymphocytic, acute, leukemia, lymphocytic, chronic, leukemia, myeloid, acute, leukemia,myeloid, chronic, metastatic cancer, myelodysplasia, myeloma